Nurix Therapeutics Inc
General ticker "NRIX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.5B
Nurix Therapeutics Inc follows the US Stock Market performance with the rate: 62.0%.
Estimated limits based on current volatility of 2.9%: low 19.35$, high 20.51$
Factors to consider:
- Current price 120.8% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-11-30 to 2025-11-29
- 2023-11-30 to 2024-11-29 estimated range: [3.66$, 8.98$]
- 2024-11-29 to 2025-11-29 estimated range: [3.79$, 9.05$]
Financial Metrics affecting the NRIX estimates:
- Negative: Non-GAAP EPS, $ of -2.65 <= 0.10
- Negative: Operating profit margin, % of -66.82 <= 1.03
- Negative: Operating cash flow per share per price, % of -20.64 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.88 <= 3.85
Short-term NRIX quotes
Long-term NRIX plot with estimates
Financial data
| YTD | 2021-11-30 | 2022-11-30 | 2023-11-30 |
|---|---|---|---|
| Operating Revenue | $29.75MM | $38.63MM | $76.99MM |
| Operating Expenses | $147.64MM | $222.49MM | $232.05MM |
| Operating Income | $-117.89MM | $-183.87MM | $-155.06MM |
| Non-Operating Income | $0.82MM | $3.51MM | $11.12MM |
| R&D Expense | $116.43MM | $184.50MM | $189.15MM |
| Income(Loss) | $-117.06MM | $-180.36MM | $-143.95MM |
| Taxes | $0.13MM | $0.00MM | $0.00MM |
| Profit(Loss) | $-117.19MM | $-180.36MM | $-143.95MM |
| Stockholders Equity | $342.30MM | $303.70MM | $200.49MM |
| Inventory | $0.00MM | $1.10MM | $0.00MM |
| Assets | $476.77MM | $416.76MM | $355.60MM |
| Operating Cash Flow | $-84.36MM | $-159.81MM | $-81.36MM |
| Capital expenditure | $5.66MM | $12.24MM | $8.40MM |
| Investing Cash Flow | $-108.25MM | $27.20MM | $68.30MM |
| Financing Cash Flow | $153.88MM | $117.19MM | $3.22MM |
| Earnings Per Share* | $-2.73 | $-3.42 | $-2.65 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.